A comparative study of extraction free detection of HBV DNA using sodium dodecyl sulfate, N-lauroylsarcosine sodium salt, and sodium dodecyl benzene sulfonate.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 Oct 2024
Historique:
received: 20 07 2024
accepted: 09 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

This study aimed to develop an extraction-free method for quantitative and qualitative detection of HBV DNA compared to traditional nucleic acid extraction. Paired serum and dried blood spot (DBS) samples from 67 HBsAg-positive and 67 HBsAg-negative individuals were included. Two samples with known HBV DNA titers (~ 10

Identifiants

pubmed: 39455809
doi: 10.1038/s41598-024-75944-7
pii: 10.1038/s41598-024-75944-7
doi:

Substances chimiques

DNA, Viral 0
Sodium Dodecyl Sulfate 368GB5141J
dodecylbenzenesulfonic acid 60NSK897G9
Benzenesulfonates 0
Surface-Active Agents 0
Hepatitis B Surface Antigens 0

Types de publication

Journal Article Comparative Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

25442

Subventions

Organisme : Japan Society for the Promotion of Science (JSPS) Core-to-Core Program
ID : JPJSCCB20210010
Organisme : Japan Society for the Promotion of Science (JSPS) Core-to-Core Program
ID : JPJSCCB20240009
Organisme : Ministry of Health, Labour and Welfare of Japan
ID : JPMH19HC1001
Organisme : Ministry of Health, Labour and Welfare of Japan
ID : JPMH22HC1001
Organisme : Fund for the promotion of Joint International Research (Fostering Joint International Research-B)
ID : JP18KK0262

Informations de copyright

© 2024. The Author(s).

Références

World_Health_Organization. Hepatitis B: WHO Fact Sheet. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b . Accessed 3 Jul 2024.
World_Health_Organization. Global Hepatitis Report 2024: Action for Access in Low- and Middle-income Countries (World Health Organization, 2024). Licence: CC BY-NC-SA 3.0 IGO.
Polaris_Observatory_Group. Country Dashboard on HBV and HCV elimination Polaris Observatory Center for Disease Analysis 2021. https://cdafound.org/polaris-countries-dashboard/ Accessed 3 Jul 2024.
Mitchell, J. RT-PCR Protocols. Methods in Molecular Biology, Vol. 193: O’Connell J, ed. ($99.50.) Humana Press, 2002. ISBN 0 89603 875 0. J. Clin. Pathol. 56, 400 (2003).
Schmitz, J. E., Stratton, C. W., Persing, D. H. & Tang, Y. W. Forty years of molecular diagnostics for infectious diseases. J. Clin. Microbiol. 60, e0244621. https://doi.org/10.1128/jcm.02446-21 (2022).
doi: 10.1128/jcm.02446-21 pubmed: 35852340
Krishna, N. K. & Cunnion, K. M. Role of molecular diagnostics in the management of infectious disease emergencies. Med. Clin. North Am. 96, 1067–1078. https://doi.org/10.1016/j.mcna.2012.08.005 (2012).
doi: 10.1016/j.mcna.2012.08.005 pubmed: 23102477 pmcid: 7172584
Tang, Y. W., Procop, G. W. & Persing, D. H. Molecular diagnostics of infectious diseases. Clin. Chem. 43, 2021–2038 (1997).
doi: 10.1093/clinchem/43.11.2021 pubmed: 9365385
Bhatt, A. et al. CLEVER assay: A visual and rapid RNA extraction-free detection of SARS-CoV-2 based on CRISPR-Cas integrated RT-LAMP technology. J. Appl. Microbiol. 133, 410–421. https://doi.org/10.1111/jam.15571 (2022).
doi: 10.1111/jam.15571 pubmed: 35396760
Liu, W., Yue, F. & Lee, L. P. Integrated point-of-care molecular diagnostic devices for infectious diseases. Acc. Chem. Res. 54, 4107–4119. https://doi.org/10.1021/acs.accounts.1c00385 (2021).
doi: 10.1021/acs.accounts.1c00385 pubmed: 34699183
Takahashi, K. et al. Demonstration of hepatitis B e antigen in the core of dane particles1. J. Immunol. 122, 275–279. https://doi.org/10.4049/jimmunol.122.1.275 (1979).
doi: 10.4049/jimmunol.122.1.275 pubmed: 105041
Hajian-Tilaki, K. Sample size estimation in diagnostic test studies of biomedical informatics. J. Biomed. Inform. 48, 193–204. https://doi.org/10.1016/j.jbi.2014.02.013 (2014).
doi: 10.1016/j.jbi.2014.02.013 pubmed: 24582925
Bunthen, E. et al. Residual risk of mother-to-child transmission of HBV despite timely Hepatitis B vaccination: A major challenge to eliminate hepatitis B infection in Cambodia. BMC Infect Dis. 23, 261. https://doi.org/10.1186/s12879-023-08249-1 (2023).
doi: 10.1186/s12879-023-08249-1
Yu, Y., Pandeya, D. R., Liu, M. L., Liu, M. J. & Hong, S. T. Expression and purification of a functional human hepatitis B virus polymerase. World J. Gastroenterol. 16, 5752–5758. https://doi.org/10.3748/wjg.v16.i45.5752 (2010).
doi: 10.3748/wjg.v16.i45.5752 pubmed: 21128327 pmcid: 2997993
Carratalá, J. V. et al. Enhanced recombinant protein capture, purity and yield from crude bacterial cell extracts by N-Lauroylsarcosine-assisted affinity chromatography. Microb. Cell Fact. 22, 81. https://doi.org/10.1186/s12934-023-02081-7 (2023).
doi: 10.1186/s12934-023-02081-7 pubmed: 37098491 pmcid: 10131332
Sood, A. K. & Aggarwal, M. Evaluation of micellar properties of sodium dodecylbenzene sulphonate in the presence of some salts. J. Chem. Sci. 130, 39. https://doi.org/10.1007/s12039-018-1446-z (2018).
doi: 10.1007/s12039-018-1446-z
Notomi, T. et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 28, E63. https://doi.org/10.1093/nar/28.12.e63 (2000).
doi: 10.1093/nar/28.12.e63 pubmed: 10871386 pmcid: 102748
Changotra, H. & Sehajpal, P. K. An improved method for the isolation of hepatitis B virus DNA from human serum. Indian J. Virol. 24, 174–179. https://doi.org/10.1007/s13337-013-0155-y (2013).
doi: 10.1007/s13337-013-0155-y pubmed: 24426273 pmcid: 3784906
Costa, J. et al. Microwave treatment of serum facilitates detection of hepatitis B virus DNA by the polymerase chain reaction. Results of a study in anti-HBe positive chronic hepatitis B. J. Hepatol. 22, 35–42. https://doi.org/10.1016/0168-8278(95)80257-6 (1995).
doi: 10.1016/0168-8278(95)80257-6 pubmed: 7751585
Kaneko, S., Feinstone, S. M. & Miller, R. H. Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J. Clin. Microbiol. 27, 1930–1933. https://doi.org/10.1128/jcm.27.9.1930-1933.1989 (1989).
doi: 10.1128/jcm.27.9.1930-1933.1989 pubmed: 2778059 pmcid: 267711
Sambrook, J. & Russell, D. W. Molecular Cloning: A Laboratory Manual 3rd edn, Vol. 1 (Cold Spring Harbor Laboratory Press, 2001).
Ko, K. et al. Existence of hepatitis B virus surface protein mutations and other variants: Demand for hepatitis B infection control in Cambodia. BMC Infect. Dis. 20, 305. https://doi.org/10.1186/s12879-020-05025-3 (2020).
doi: 10.1186/s12879-020-05025-3 pubmed: 32334529 pmcid: 7183719
World_Health_Organization. Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Natarajan, V. P., Zhang, X., Morono, Y., Inagaki, F. & Wang, F. A modified SDS-based DNA extraction method for high quality environmental DNA from seafloor environments. Front. Microbiol. 7, 986. https://doi.org/10.3389/fmicb.2016.00986 (2016).
doi: 10.3389/fmicb.2016.00986 pubmed: 27446026 pmcid: 4917542
Mohamed, S. et al. Dried blood spot sampling for hepatitis B virus serology and molecular testing. PLoS ONE 8, e61077. https://doi.org/10.1371/journal.pone.0061077 (2013).
doi: 10.1371/journal.pone.0061077 pubmed: 23613788 pmcid: 3628702
Kikuchi, M. et al. Dried blood spot is the feasible matrix for detection of some but not all hepatitis B virus markers of infection. BMC Res. Notes 15, 287. https://doi.org/10.1186/s13104-022-06178-x (2022).
doi: 10.1186/s13104-022-06178-x pubmed: 36064629 pmcid: 9446784
Stene-Johansen, K. et al. Dry blood spots a reliable method for measurement of hepatitis B viral load in resource-limited settings. PLoS ONE 11, e0166201. https://doi.org/10.1371/journal.pone.0166201 (2016).
doi: 10.1371/journal.pone.0166201 pubmed: 27820845 pmcid: 5098817
Garg, R., Ramachandran, K., Jayashree, S., Agarwal, R. & Gupta, E. Evaluation of blood samples collected by dried blood spots (DBS) method for hepatitis B virus DNA quantitation and its stability under real life conditions. J. Clin. Virol. Plus 2, 100111. https://doi.org/10.1016/j.jcvp.2022.100111 (2022).
doi: 10.1016/j.jcvp.2022.100111
Vinikoor, M. J. et al. Hepatitis B viral load in dried blood spots: A validation study in Zambia. J. Clin. Virol. 72, 20–24. https://doi.org/10.1016/j.jcv.2015.08.019 (2015).
doi: 10.1016/j.jcv.2015.08.019 pubmed: 26356987 pmcid: 4959444
Al-Soud, W. A. & Rådström, P. Purification and characterization of PCR-inhibitory components in blood cells. J. Clin. Microbiol. 39, 485–493. https://doi.org/10.1128/jcm.39.2.485-493.2001 (2001).
doi: 10.1128/jcm.39.2.485-493.2001 pubmed: 11158094 pmcid: 87763
Urban, S. et al. Isolation and molecular characterization of hepatitis B virus X-protein from a baculovirus expression system. Hepatology 26, 1045–1053. https://doi.org/10.1053/jhep.1997.v26.pm0009328333 (1997).
doi: 10.1053/jhep.1997.v26.pm0009328333 pubmed: 9328333
Gerlich, W. H. & Robinson, W. S. Hepatitis B virus contains protein attached to the 5’ terminus of its complete DNA strand. Cell 21, 801–809. https://doi.org/10.1016/0092-8674(80)90443-2 (1980).
doi: 10.1016/0092-8674(80)90443-2 pubmed: 7438207
Kreader, C. A. Relief of amplification inhibition in PCR with bovine serum albumin or T4 gene 32 protein. Appl. Environ. Microbiol. 62, 1102–1106. https://doi.org/10.1128/aem.62.3.1102-1106.1996 (1996).
doi: 10.1128/aem.62.3.1102-1106.1996 pubmed: 8975603 pmcid: 167874
Woide, D., Zink, A. & Thalhammer, S. Technical note: PCR analysis of minimum target amount of ancient DNA. Am. J. Phys. Anthropol. 142, 321–327. https://doi.org/10.1002/ajpa.21268 (2010).
doi: 10.1002/ajpa.21268 pubmed: 20229501
Tarrand, J. J., Krieg, N. R. & Döbereiner, J. A taxonomic study of the Spirillum lipoferum group, with descriptions of a new genus, Azospirillum gen. nov. and two species, Azospirillum lipoferum (Beijerinck) comb nov. and Azospirillum brasilense sp. nov.. Can J Microbiol 24, 967–980. https://doi.org/10.1139/m78-160 (1978).
doi: 10.1139/m78-160 pubmed: 356945
Vanhomwegen, J. et al. Development and clinical validation of loop-mediated isothermal amplification (LAMP) assay to diagnose high HBV DNA levels in resource-limited settings. Clin. Microbiol. Infect. 27(1858), e1859-1858.e1815. https://doi.org/10.1016/j.cmi.2021.03.014 (2021).
doi: 10.1016/j.cmi.2021.03.014
Chen, C. M. et al. Diagnostic accuracy of LAMP assay for HBV infection. J Clin. Lab. Anal. 34, e23281. https://doi.org/10.1002/jcla.23281 (2020).
doi: 10.1002/jcla.23281 pubmed: 32157743 pmcid: 7370716
Mayran, C. et al. Rapid diagnostic test for hepatitis B virus viral load based on recombinase polymerase amplification combined with a lateral flow read-out. Diagnostics. https://doi.org/10.3390/diagnostics12030621 (2022).
doi: 10.3390/diagnostics12030621 pubmed: 35328174 pmcid: 8946908
Sun, M. L., Zhong, Y., Li, X. N., Yao, J. & Pan, Y. Q. Simple and feasible detection of hepatitis a virus using reverse transcription multienzyme isothermal rapid amplification and lateral flow dipsticks without standard PCR laboratory. Artif. Cells Nanomed. Biotechnol. 51, 233–240. https://doi.org/10.1080/21691401.2023.2203198 (2023).
doi: 10.1080/21691401.2023.2203198 pubmed: 37102677
Shen, X. X. et al. A rapid and sensitive recombinase aided amplification assay to detect hepatitis B virus without DNA extraction. BMC Infect. Dis. 19, 229. https://doi.org/10.1186/s12879-019-3814-9 (2019).
doi: 10.1186/s12879-019-3814-9 pubmed: 30836947 pmcid: 6402085
Lin, L., Guo, J., Liu, H. & Jiang, X. Rapid detection of hepatitis B virus in blood samples using a combination of polymerase spiral reaction with nanoparticles lateral-flow biosensor. Front. Mol. Biosci. 7, 578892. https://doi.org/10.3389/fmolb.2020.578892 (2020).
doi: 10.3389/fmolb.2020.578892 pubmed: 33490102
Du, Y. et al. Amplification-free detection of HBV DNA mediated by CRISPR-Cas12a using surface-enhanced Raman spectroscopy. Anal. Chim. Acta 1245, 340864. https://doi.org/10.1016/j.aca.2023.340864 (2023).
doi: 10.1016/j.aca.2023.340864 pubmed: 36737140

Auteurs

Ko Ko (K)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Hiroshima University, Hiroshima, Japan.

Lyubov Mikhailovna Lokteva (LM)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Research Institute of Virology, Tashkent, Uzbekistan.

Golda Ataa Akuffo (GA)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Hiroshima University, Hiroshima, Japan.

Zayar Phyo (Z)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Hiroshima University, Hiroshima, Japan.

Chanroth Chhoung (C)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Hiroshima University, Hiroshima, Japan.

E Bunthen (E)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
National Payment Certification Agency, National Social Protection Council, Ministry of Economic and Finance, Phnom Penh, Cambodia.

Serge Ouoba (S)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Science de La Santé (IRSS), Nanoro, Burkina Faso.

Aya Sugiyama (A)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Hiroshima University, Hiroshima, Japan.

Tomoyuki Akita (T)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Hiroshima University, Hiroshima, Japan.

Kim Rattana (K)

National Maternal and Child Health Center (NMCHC), Ministry of Health, Phnom Penh, Cambodia.

Ork Vichit (O)

National Immunization Program (NIP), Ministry of Health, Phnom Penh, Cambodia.

Kazuaki Takahashi (K)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan.
Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Hiroshima University, Hiroshima, Japan.

Junko Tanaka (J)

Department of Epidemiology, Infectious Disease Control and Prevention, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3, Kasumi, Minami, Hiroshima, 734-8551, Japan. jun-tanaka@hiroshima-u.ac.jp.
Project Research Center for Epidemiology and Prevention of Viral Hepatitis and Hepatocellular Carcinoma, Hiroshima University, Hiroshima, Japan. jun-tanaka@hiroshima-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH